Global Cannabis Use Disorder Treatment Market Growth (Status and Outlook) 2026-2032

April 2026 | 106 pages | ID: G33D5C878C7CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Cannabis Use Disorder Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Cannabis Use Disorder Treatment Industry Forecast? looks at past sales and reviews total world Cannabis Use Disorder Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Cannabis Use Disorder Treatment sales for 2026 through 2032. With Cannabis Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis Use Disorder Treatment industry.

This Insight Report provides a comprehensive analysis of the global Cannabis Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cannabis Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cannabis Use Disorder Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis Use Disorder Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis Use Disorder Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Tobacco/Nicotine and Vaping
  • Alcohol
  • Marijuana
  • Synthetic Cannabinoids
  • Others
Segmentation by Application:
  • Hospitals and Clinics
  • Rehabilitation Centers
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AbbVie
  • Alkermes
  • BioCorRx
  • Cipla Limited
  • Dr. Reddy?s Laboratories
  • Glenmark Pharmaceuticals Limited
  • Intas Pharmaceuticals Limited
  • Indivior
  • Mallinckrodt
  • Noramco
  • Orexo AB
  • Purdue Pharma
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cannabis Use Disorder Treatment Market Size (2021-2032)
  2.1.2 Cannabis Use Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Cannabis Use Disorder Treatment by Country/Region (2021, 2025 & 2032)
2.2 Cannabis Use Disorder Treatment Segment by Type
  2.2.1 Tobacco/Nicotine and Vaping
  2.2.2 Alcohol
  2.2.3 Marijuana
  2.2.4 Synthetic Cannabinoids
  2.2.5 Others
  2.2.6 Cannabis Use Disorder Treatment Market Size by Type
    2.2.6.1 Cannabis Use Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
2.3 Cannabis Use Disorder Treatment Segment by Application
  2.3.1 Hospitals and Clinics
  2.3.2 Rehabilitation Centers
  2.3.3 Others
  2.3.4 Cannabis Use Disorder Treatment Market Size by Application
    2.3.4.1 Cannabis Use Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)

3 CANNABIS USE DISORDER TREATMENT MARKET SIZE BY PLAYER

3.1 Cannabis Use Disorder Treatment Market Size Market Share by Player
  3.1.1 Global Cannabis Use Disorder Treatment Revenue by Player (2021-2026)
  3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Cannabis Use Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANNABIS USE DISORDER TREATMENT BY REGION

4.1 Cannabis Use Disorder Treatment Market Size by Region (2021-2026)
4.2 Global Cannabis Use Disorder Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cannabis Use Disorder Treatment Market Size Growth (2021-2026)
4.4 APAC Cannabis Use Disorder Treatment Market Size Growth (2021-2026)
4.5 Europe Cannabis Use Disorder Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Cannabis Use Disorder Treatment Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Cannabis Use Disorder Treatment Market Size by Country (2021-2026)
5.2 Americas Cannabis Use Disorder Treatment Market Size by Type (2021-2026)
5.3 Americas Cannabis Use Disorder Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cannabis Use Disorder Treatment Market Size by Region (2021-2026)
6.2 APAC Cannabis Use Disorder Treatment Market Size by Type (2021-2026)
6.3 APAC Cannabis Use Disorder Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cannabis Use Disorder Treatment Market Size by Country (2021-2026)
7.2 Europe Cannabis Use Disorder Treatment Market Size by Type (2021-2026)
7.3 Europe Cannabis Use Disorder Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cannabis Use Disorder Treatment by Region (2021-2026)
8.2 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANNABIS USE DISORDER TREATMENT MARKET FORECAST

10.1 Global Cannabis Use Disorder Treatment Forecast by Region (2027-2032)
  10.1.1 Global Cannabis Use Disorder Treatment Forecast by Region (2027-2032)
  10.1.2 Americas Cannabis Use Disorder Treatment Forecast
  10.1.3 APAC Cannabis Use Disorder Treatment Forecast
  10.1.4 Europe Cannabis Use Disorder Treatment Forecast
  10.1.5 Middle East & Africa Cannabis Use Disorder Treatment Forecast
10.2 Americas Cannabis Use Disorder Treatment Forecast by Country (2027-2032)
  10.2.1 United States Market Cannabis Use Disorder Treatment Forecast
  10.2.2 Canada Market Cannabis Use Disorder Treatment Forecast
  10.2.3 Mexico Market Cannabis Use Disorder Treatment Forecast
  10.2.4 Brazil Market Cannabis Use Disorder Treatment Forecast
10.3 APAC Cannabis Use Disorder Treatment Forecast by Region (2027-2032)
  10.3.1 China Cannabis Use Disorder Treatment Market Forecast
  10.3.2 Japan Market Cannabis Use Disorder Treatment Forecast
  10.3.3 Korea Market Cannabis Use Disorder Treatment Forecast
  10.3.4 Southeast Asia Market Cannabis Use Disorder Treatment Forecast
  10.3.5 India Market Cannabis Use Disorder Treatment Forecast
  10.3.6 Australia Market Cannabis Use Disorder Treatment Forecast
10.4 Europe Cannabis Use Disorder Treatment Forecast by Country (2027-2032)
  10.4.1 Germany Market Cannabis Use Disorder Treatment Forecast
  10.4.2 France Market Cannabis Use Disorder Treatment Forecast
  10.4.3 UK Market Cannabis Use Disorder Treatment Forecast
  10.4.4 Italy Market Cannabis Use Disorder Treatment Forecast
  10.4.5 Russia Market Cannabis Use Disorder Treatment Forecast
10.5 Middle East & Africa Cannabis Use Disorder Treatment Forecast by Region (2027-2032)
  10.5.1 Egypt Market Cannabis Use Disorder Treatment Forecast
  10.5.2 South Africa Market Cannabis Use Disorder Treatment Forecast
  10.5.3 Israel Market Cannabis Use Disorder Treatment Forecast
  10.5.4 Turkey Market Cannabis Use Disorder Treatment Forecast
10.6 Global Cannabis Use Disorder Treatment Forecast by Type (2027-2032)
10.7 Global Cannabis Use Disorder Treatment Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Cannabis Use Disorder Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Cannabis Use Disorder Treatment Product Offered
  11.1.3 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Alkermes
  11.2.1 Alkermes Company Information
  11.2.2 Alkermes Cannabis Use Disorder Treatment Product Offered
  11.2.3 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Alkermes Main Business Overview
  11.2.5 Alkermes Latest Developments
11.3 BioCorRx
  11.3.1 BioCorRx Company Information
  11.3.2 BioCorRx Cannabis Use Disorder Treatment Product Offered
  11.3.3 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 BioCorRx Main Business Overview
  11.3.5 BioCorRx Latest Developments
11.4 Cipla Limited
  11.4.1 Cipla Limited Company Information
  11.4.2 Cipla Limited Cannabis Use Disorder Treatment Product Offered
  11.4.3 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Cipla Limited Main Business Overview
  11.4.5 Cipla Limited Latest Developments
11.5 Dr. Reddy?s Laboratories
  11.5.1 Dr. Reddy?s Laboratories Company Information
  11.5.2 Dr. Reddy?s Laboratories Cannabis Use Disorder Treatment Product Offered
  11.5.3 Dr. Reddy?s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Dr. Reddy?s Laboratories Main Business Overview
  11.5.5 Dr. Reddy?s Laboratories Latest Developments
11.6 Glenmark Pharmaceuticals Limited
  11.6.1 Glenmark Pharmaceuticals Limited Company Information
  11.6.2 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered
  11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Glenmark Pharmaceuticals Limited Main Business Overview
  11.6.5 Glenmark Pharmaceuticals Limited Latest Developments
11.7 Intas Pharmaceuticals Limited
  11.7.1 Intas Pharmaceuticals Limited Company Information
  11.7.2 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered
  11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Intas Pharmaceuticals Limited Main Business Overview
  11.7.5 Intas Pharmaceuticals Limited Latest Developments
11.8 Indivior
  11.8.1 Indivior Company Information
  11.8.2 Indivior Cannabis Use Disorder Treatment Product Offered
  11.8.3 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Indivior Main Business Overview
  11.8.5 Indivior Latest Developments
11.9 Mallinckrodt
  11.9.1 Mallinckrodt Company Information
  11.9.2 Mallinckrodt Cannabis Use Disorder Treatment Product Offered
  11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Mallinckrodt Main Business Overview
  11.9.5 Mallinckrodt Latest Developments
11.10 Noramco
  11.10.1 Noramco Company Information
  11.10.2 Noramco Cannabis Use Disorder Treatment Product Offered
  11.10.3 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Noramco Main Business Overview
  11.10.5 Noramco Latest Developments
11.11 Orexo AB
  11.11.1 Orexo AB Company Information
  11.11.2 Orexo AB Cannabis Use Disorder Treatment Product Offered
  11.11.3 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Orexo AB Main Business Overview
  11.11.5 Orexo AB Latest Developments
11.12 Purdue Pharma
  11.12.1 Purdue Pharma Company Information
  11.12.2 Purdue Pharma Cannabis Use Disorder Treatment Product Offered
  11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Purdue Pharma Main Business Overview
  11.12.5 Purdue Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Cannabis Use Disorder Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cannabis Use Disorder Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tobacco/Nicotine and Vaping
Table 4. Major Players of Alcohol
Table 5. Major Players of Marijuana
Table 6. Major Players of Synthetic Cannabinoids
Table 7. Major Players of Others
Table 8. Cannabis Use Disorder Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cannabis Use Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 11. Cannabis Use Disorder Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cannabis Use Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 14. Global Cannabis Use Disorder Treatment Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Cannabis Use Disorder Treatment Revenue Market Share by Player (2021-2026)
Table 16. Cannabis Use Disorder Treatment Key Players Head office and Products Offered
Table 17. Cannabis Use Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cannabis Use Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Cannabis Use Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 22. Global Cannabis Use Disorder Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Cannabis Use Disorder Treatment Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Cannabis Use Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Cannabis Use Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 26. Americas Cannabis Use Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
Table 28. Americas Cannabis Use Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)
Table 30. APAC Cannabis Use Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Cannabis Use Disorder Treatment Market Size Market Share by Region (2021-2026)
Table 32. APAC Cannabis Use Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Cannabis Use Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Cannabis Use Disorder Treatment Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Cannabis Use Disorder Treatment Market Size Market Share by Country (2021-2026)
Table 36. Europe Cannabis Use Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Cannabis Use Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cannabis Use Disorder Treatment
Table 42. Key Market Challenges & Risks of Cannabis Use Disorder Treatment
Table 43. Key Industry Trends of Cannabis Use Disorder Treatment
Table 44. Global Cannabis Use Disorder Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Cannabis Use Disorder Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Cannabis Use Disorder Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Cannabis Use Disorder Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. AbbVie Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 49. AbbVie Cannabis Use Disorder Treatment Product Offered
Table 50. AbbVie Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. AbbVie Main Business
Table 52. AbbVie Latest Developments
Table 53. Alkermes Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 54. Alkermes Cannabis Use Disorder Treatment Product Offered
Table 55. Alkermes Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Alkermes Main Business
Table 57. Alkermes Latest Developments
Table 58. BioCorRx Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 59. BioCorRx Cannabis Use Disorder Treatment Product Offered
Table 60. BioCorRx Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. BioCorRx Main Business
Table 62. BioCorRx Latest Developments
Table 63. Cipla Limited Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 64. Cipla Limited Cannabis Use Disorder Treatment Product Offered
Table 65. Cipla Limited Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Cipla Limited Main Business
Table 67. Cipla Limited Latest Developments
Table 68. Dr. Reddy?s Laboratories Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 69. Dr. Reddy?s Laboratories Cannabis Use Disorder Treatment Product Offered
Table 70. Dr. Reddy?s Laboratories Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Dr. Reddy?s Laboratories Main Business
Table 72. Dr. Reddy?s Laboratories Latest Developments
Table 73. Glenmark Pharmaceuticals Limited Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 74. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered
Table 75. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Glenmark Pharmaceuticals Limited Main Business
Table 77. Glenmark Pharmaceuticals Limited Latest Developments
Table 78. Intas Pharmaceuticals Limited Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 79. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Offered
Table 80. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Intas Pharmaceuticals Limited Main Business
Table 82. Intas Pharmaceuticals Limited Latest Developments
Table 83. Indivior Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 84. Indivior Cannabis Use Disorder Treatment Product Offered
Table 85. Indivior Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Indivior Main Business
Table 87. Indivior Latest Developments
Table 88. Mallinckrodt Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 89. Mallinckrodt Cannabis Use Disorder Treatment Product Offered
Table 90. Mallinckrodt Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Mallinckrodt Main Business
Table 92. Mallinckrodt Latest Developments
Table 93. Noramco Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 94. Noramco Cannabis Use Disorder Treatment Product Offered
Table 95. Noramco Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Noramco Main Business
Table 97. Noramco Latest Developments
Table 98. Orexo AB Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 99. Orexo AB Cannabis Use Disorder Treatment Product Offered
Table 100. Orexo AB Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Orexo AB Main Business
Table 102. Orexo AB Latest Developments
Table 103. Purdue Pharma Details, Company Type, Cannabis Use Disorder Treatment Area Served and Its Competitors
Table 104. Purdue Pharma Cannabis Use Disorder Treatment Product Offered
Table 105. Purdue Pharma Cannabis Use Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Purdue Pharma Main Business
Table 107. Purdue Pharma Latest Developments

LIST OF FIGURES

Figure 1. Cannabis Use Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cannabis Use Disorder Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cannabis Use Disorder Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cannabis Use Disorder Treatment Sales Market Share by Country/Region (2025)
Figure 8. Cannabis Use Disorder Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cannabis Use Disorder Treatment Market Size Market Share by Type in 2025
Figure 10. Cannabis Use Disorder Treatment in Hospitals and Clinics
Figure 11. Global Cannabis Use Disorder Treatment Market: Hospitals and Clinics (2021-2026) & ($ millions)
Figure 12. Cannabis Use Disorder Treatment in Rehabilitation Centers
Figure 13. Global Cannabis Use Disorder Treatment Market: Rehabilitation Centers (2021-2026) & ($ millions)
Figure 14. Cannabis Use Disorder Treatment in Others
Figure 15. Global Cannabis Use Disorder Treatment Market: Others (2021-2026) & ($ millions)
Figure 16. Global Cannabis Use Disorder Treatment Market Size Market Share by Application in 2025
Figure 17. Global Cannabis Use Disorder Treatment Revenue Market Share by Player in 2025
Figure 18. Global Cannabis Use Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Cannabis Use Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Cannabis Use Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Cannabis Use Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Cannabis Use Disorder Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Cannabis Use Disorder Treatment Value Market Share by Country in 2025
Figure 24. United States Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Cannabis Use Disorder Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Cannabis Use Disorder Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Cannabis Use Disorder Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Cannabis Use Disorder Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Cannabis Use Disorder Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Cannabis Use Disorder Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Cannabis Use Disorder Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Cannabis Use Disorder Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Cannabis Use Disorder Treatment Market Size 2027-2032 ($ millions)


More Publications